COL1A2 and osteogenesis imperfecta: While osteogenesis imperfecta and osteoporosis are distinct conditions, rare deleterious variants in COL1A2 are associated with reduced BMD and increased fracture risk in population-based studies [57–60], suggesting a potential overlap in genetic pathways contributing to bone strength and fragility.